About
Basic Data Updated:
2 years agoIt is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543064 and on the National Stock Exchange(NSE) under SUVENPHAR.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 40.00 cr and a paid-up capital of Rs 25.46 cr.
The Corporate currently has active open charges totaling ₹174.02 cr.
The Key Managerial Personnel (KMP) at Suven Pharmaceuticals Limited India are P Rao serving as the Chief Financial Officer (CFO) and Hanumantha Kokkonda as Company Secretary. Govinda Dasu, Venkateswarlu Jasti, Srivari Chandrasekhar, and Four other members serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
Products or Services related to Suven Pharmaceuticals Limited
Activation Powder
Industrial Cleaning Machine
Insulin Syringe
Financials of Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.27% increase. The company also saw a substantial improvement in profitability, with a 80.82% increase in profit. The company's net worth Soared by an impressive increase of 42.76%.
Corporate Structure
Unlock access to Suven Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Suven Pharmaceuticals Limited
Unlock and access historical data on people associated with Suven Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
VJ
Venkateswarlu Jasti
Managing DirectorAppointment Date: 06-Nov-2019
Status: Current
PR
P Rao
CFO(Kmp)Appointment Date: 10-Jan-2020
Status: Current
HK
Hanumantha Kokkonda Company SecretaryAppointment Date: 10-Jan-2020
Status: Current
Board Members(6)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Bahrain And Kuwait Bsc Creation Date: 29 Dec 2020 | ₹10.00 Cr | Open |
State Bank Of India Creation Date: 05 Nov 2020 | ₹164.02 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suven Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
The Federation Of Telangana Chambers Of Commerce And Industry
Active
59 years 4 months Venkateswarlu Jasti is a mutual person
Suven Life Sciences Limited
Active 35 years 2 months Venkateswarlu Jasti and Vajja Rao are mutual person
Recent activity within the organization
Annual General Meeting
Suven Pharmaceuticals Limited last Annual general meeting of members was held on 31 Aug 2021 as per latest MCA records.
31 Aug 2021Balance Sheet
Suven Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with RoC-Hyderabad.
31 Mar 2021Charges
A charge with Bank Of Bahrain And Kuwait Bsc amounted to Rs. 10.00 cr with Charge ID 100402459 was registered on 29 Dec 2020.
29 Dec 2020Charges
A charge with State Bank Of India of Rs. 164.02 cr registered on 05 Nov 2020 with Charge ID 100391471 was modified on 28 Dec 2020.
28 Dec 2020Charges
A charge with State Bank Of India amounted to Rs. 164.02 cr with Charge ID 100391471 was registered on 05 Nov 2020.
05 Nov 2020
Recent News, Updates & Announcement
Advent kickstarts merger process of Suven Pharma Cohance engages Kotak Citi.Moneycontrol 07 Feb 2024
- Cabinet nod to Rs 9589cr FDI in Suven Pharma.
The Tribune 14 Sep 2023
- Cabinet approves Rs 9589 crore FDI in Suven Pharma.
Deccan Herald 14 Sep 2023
- Advent gets Cabinets green signal to acquire Suven Pharma for Rs 9589 crore.
India Infoline 14 Sep 2023
- Suven Pharma Q1 net profit rises 1212 to Rs 1205 crore.
Moneycontrol 09 Aug 2023
Frequently asked questions
What is the Incorporation or founding date of Suven Pharmaceuticals Limited?
